HIGHLIGHTS
- who: Sam Polesie from the variable in the regression modelIn all analyses, we analysed BCC, cSCC and CMM separately and never-use of MTX was the reference group. To evaluate effect measure modification (heterogeneity) according to specific patient/skin cancer characteristics, we computed fully adjusted ORs in subgroups of sex, age (andlt have published the research: Use of methotrexate and risk of skin cancer: a nationwide case-control study, in the Journal: (JOURNAL) of 17/06/2022
- what: The Danish registries and databases used for this study have been comprehensively described in previous investigations , and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.